These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 17605409)

  • 1. The serologic markers of hepatitis B virus infection--proper selection and standardized interpretation.
    Caspari G; Gerlich WH
    Clin Lab; 2007; 53(5-6):335-43, 391-400. PubMed ID: 17605409
    [No Abstract]   [Full Text] [Related]  

  • 2. [Vaccination and serologic markers of hepatitis B virus infection].
    Salmeron Garcia F; Echevarria Mayo JM
    Rev Sanid Hig Publica (Madr); 1990; 64(3-4):141-50. PubMed ID: 2131596
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Atypical profile of markers of hepatitis B and vaccination].
    Velosa J
    Acta Med Port; 1996; 9(7-9):247-51. PubMed ID: 9005705
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Atypical serologic patterns in hepatitis B virus infection].
    Muñoz Criado S; Muñoz Bellido JL; García Rodríguez JA
    Rev Clin Esp; 1997 Jul; 197(7):507-11. PubMed ID: 9411549
    [No Abstract]   [Full Text] [Related]  

  • 5. [Hepatitis B].
    Kashiwagi S
    Nihon Rinsho; 2003 Feb; 61 Suppl 2():236-40. PubMed ID: 12722220
    [No Abstract]   [Full Text] [Related]  

  • 6. [Viral marker related to antigen and antibody of hepatitis B virus].
    Arase Y
    Nihon Rinsho; 2010 Jun; 68 Suppl 6():439-42. PubMed ID: 20942098
    [No Abstract]   [Full Text] [Related]  

  • 7. Efficacy of serologic marker screening in identifying hepatitis B virus infection in organ, tissue, and cell donors.
    Challine D; Chevaliez S; Pawlotsky JM
    Gastroenterology; 2008 Oct; 135(4):1185-91. PubMed ID: 18694749
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Design of a vaccination campaign against hepatitis b virus].
    Canga A; Sanchez M; Fernandez E; Martinez J; Arcos P; Suarez MT
    Rev Sanid Hig Publica (Madr); 1990; 64(3-4):211-7. PubMed ID: 2131602
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The prevalence of serum markers of the hepatitis B virus in the personnel of a general hospital].
    Jaqueti J; Pérez-Piqueras J; Martínez-Hernández D; Blasco Ferrándiz R; Nicolás D; Navarro-Gallar F
    Rev Esp Enferm Dig; 1992 Jul; 82(1):63-5. PubMed ID: 1520557
    [No Abstract]   [Full Text] [Related]  

  • 10. [Prevalence of serologic markers of hepatitis B virus in non-hospital health personnel].
    López Martínez RM; Cervera Estrany M; Planells Torres P; Juvé Saumell R
    Med Clin (Barc); 1994 Oct; 103(10):396. PubMed ID: 7983906
    [No Abstract]   [Full Text] [Related]  

  • 11. [Nucleic acid-based testing for hepatitis B viruss infectious disease].
    Tanaka Y; Mizokami M
    Nihon Rinsho; 2005 Dec; 63 Suppl 12():331-7. PubMed ID: 16416814
    [No Abstract]   [Full Text] [Related]  

  • 12. Trends in prevalence of hepatitis B virus infection among Iranian blood donors, 1998-2007.
    Kafi-abad SA; Rezvan H; Abolghasemi H
    Transfus Med; 2009 Aug; 19(4):189-94. PubMed ID: 19708860
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatitis B virus infection: understanding its epidemiology, course, and diagnosis.
    Elgouhari HM; Abu-Rajab Tamimi TI; Carey WD
    Cleve Clin J Med; 2008 Dec; 75(12):881-9. PubMed ID: 19088007
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictors and kinetics of occult hepatitis B virus infection in HIV-infected persons.
    Nebbia G; Garcia-Diaz A; Ayliffe U; Smith C; Dervisevic S; Johnson M; Gilson R; Tedder R; Geretti AM
    J Med Virol; 2007 Oct; 79(10):1464-71. PubMed ID: 17705185
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evolution of hepatitis B serological markers in HIV-infected patients receiving highly active antiretroviral therapy.
    Sheng WH; Kao JH; Chen PJ; Huang LM; Chang SY; Sun HY; Hung CC; Chen MY; Chang SC
    Clin Infect Dis; 2007 Nov; 45(9):1221-9. PubMed ID: 17918088
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Response to hepatitis B virus vaccination in haemodialysis patients with and without hepatitis C infection.
    Sorkhi H; Roushan MR; Al Hashemi GH; Dooki MR; Bai S
    East Mediterr Health J; 2008; 14(4):798-803. PubMed ID: 19166162
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Incidence of HAV and HBV infections and vaccination rates in patients with autoimmune liver diseases.
    Wörns MA; Teufel A; Kanzler S; Shrestha A; Victor A; Otto G; Lohse AW; Galle PR; Höhler T
    Am J Gastroenterol; 2008 Jan; 103(1):138-46. PubMed ID: 17970833
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Does hepatitis B serology mean infection or immunity?
    Waring L; Reed C
    Aust Fam Physician; 2000 Feb; 29(2):154-5. PubMed ID: 10743271
    [No Abstract]   [Full Text] [Related]  

  • 19. Eight years of hepatitis B vaccination in Colombia with a recombinant vaccine: factors influencing hepatitis B virus infection and effectiveness.
    de la Hoz F; Perez L; de Neira M; Hall AJ
    Int J Infect Dis; 2008 Mar; 12(2):183-9. PubMed ID: 17913535
    [TBL] [Abstract][Full Text] [Related]  

  • 20. About the relationship between infection and atherosclerosis: the importance of adequate serological markers.
    Vassalle C; Zucchelli GC; Giustini C
    Atherosclerosis; 2004 Nov; 177(1):211-2; author reply 213-4. PubMed ID: 15488886
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.